|
1
|
Kasprzak KS, Sunderman FW Jr and Salnikow
K: Nickel carcinogenesis. Mutat Res. 533:67–97. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kasprzak KS: Possible role of oxidative
damage in metal-induced carcinogenesis. Cancer Invest. 13:411–430.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lynn S, Yew FH, Chen KS and Jan KY:
Reactive oxygen species are involved in nickel inhibition of DNA
repair. Environ Mol Mutagen. 29:208–216. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Aust AE and Eveleigh JF: Mechanisms of DNA
oxidation. Proc Soc Exp Biol Med. 222:246–252. 1999. View Article : Google Scholar
|
|
5
|
Chakrabarti SK, Bai C and Subramanian KS:
DNA-protein crosslinks induced by nickel compounds in isolated rat
lymphocytes: role of reactive oxygen species and specific amino
acids. Toxicol Appl Pharmacol. 170:153–165. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen XL and Kunsch C: Induction of
cytoprotective genes through Nrf2/antioxidant response element
pathway: a new therapeutic approach for the treatment of
inflammatory diseases. Curr Pharm Des. 10:879–891. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nguyen T, Nioi P and Pickett CB: The
Nrf2-antioxidant response element signaling pathway and its
activation by oxidative stress. J Biol Chem. 284:13291–13295. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Park JY and Seo YR: Enhancement of
mitomycin C-induced apoptosis in Nrf2-deficient human colon cancer
cells. Mol Cell Toxicol. 6:51–56. 2010. View Article : Google Scholar
|
|
9
|
Giudice A and Montella M: Activation of
the Nrf2-ARE signaling pathway: a promising strategy in cancer
prevention. Bioessays. 28:169–181. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ramos-Gomez M, Kwak MK, Dolan PM, Itoh K,
Yamamoto M, Talalay P and Kensler TW: Sensitivity to carcinogenesis
is increased and chemoprotective efficacy of enzyme inducers is
lost in nrf2 transcription factor-deficient mice. Proc Natl Acad
Sci USA. 98:3410–3415. 2001. View Article : Google Scholar
|
|
11
|
Osburn WO and Kensler TW: Nrf2 signaling:
an adaptive response pathway for protection against environmental
toxic insults. Mutat Res. 659:31–39. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Park JY and Seo YR: The protective role of
Nrf2 in cadmium-induced DNA damage. Mol Cell Toxicol. 7:61–66.
2011. View Article : Google Scholar
|
|
13
|
d’Errico A, Malats N, Vineis P and
Boffetta P: Review of studies of selected metabolic polymorphisms
and cancer. IARC Sci Publ. 148:323–393. 1999.PubMed/NCBI
|
|
14
|
Masuko H, Sakamoto T, Kaneko Y, et al: An
interaction between Nrf2 polymorphisms and smoking status affects
annual decline in FEV1: a longitudinal retrospective cohort study.
BMC Med Genet. 20:12–97. 2011.PubMed/NCBI
|
|
15
|
Koizumi S and Yamada H: DNA microarray
analysis of altered gene expression in cadmium-exposed human cells.
J Occup Health. 45:331–334. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Carinci F, Pezzetti F, Volinia S,
Francioso F, Arcelli D, Farina E and Piattelli A: Zirconium oxide:
analysis of MG63 osteoblast-like cell response by means of a
microarray technology. Biomaterials. 25:215–228. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Boverhof DR and Zacharewski TR:
Toxicogenomics in risk assessment: applications and needs. Toxicol
Sci. 89:352–360. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Werner T: Bioinformatics applications for
pathway analysis of microarray data. Curr Opin Biotechnol.
19:50–54. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Snow ET: Metal carcinogenesis: mechanistic
implications. Pharmacol Ther. 53:31–65. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ercal N, Gurer-Orhan H and Aykin-Burns N:
Toxic metals and oxidative stress part I: mechanisms involved in
metal-induced oxidative damage. Curr Top Med Chem. 1:529–539. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Singh NP, McCoy MT, Tice RR and Schneider
EL: A simple technique for quantitation of low levels of DNA damage
in individual cells. Exp Cell Res. 175:184–191. 1988. View Article : Google Scholar
|
|
22
|
Peng X, Wood CL, Blalock EM, Chen KC,
Landfield PW and Stromberg AJ: Statistical implications of pooling
RNA samples for microarray experiments. BMC Bioinformatics. 4:1–9.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nikitin A, Egorov S, Daraselia N and Mazo
I: Pathway studio - the analysis and navigation of molecular
networks. Bioinformatics. 19:2155–2157. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sunderman FW Jr, Dingle B, Hopfer SM and
Swift T: Acute nickel toxicity in electroplating workers who
accidently ingested a solution of nickel sulfate and nickel
chloride. Am J Ind Med. 14:257–266. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen CY, Su YJ, Wu PF and Shyu MM:
Nickel-induced plasma lipid peroxidation and effect of antioxidants
in human blood: involvement hydroxyl radical formation and
depletion of alpha-tocopherol. J Toxicol Environ Health A.
65:843–852. 2002. View Article : Google Scholar
|
|
26
|
Gong P and Cederbaum AI: Nrf2 is increased
by CYP2E1 in rodent liver and HepG2 cells and protects against
oxidative stress caused by CYP2E1. Hepatology. 43:144–153. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Aoki Y, Sato H, Nishimura N, Takahashi S,
Itoh K and Yamamoto M: Accelerated DNA adduct formation in the lung
of the Nrf2 knockout mouse exposed to diesel exhaust. Toxicol Appl
Pharmacol. 173:154–160. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shatz M and Liscovitch M: Caveolin-1: a
tumor-promoting role in human cancer. Int J Radiat Biol.
84:177–189. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Milde-Langosch K: The Fos family of
transcription factors and their role in tumourigenesis. Eur J
Cancer. 41:2449–2461. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Milde-Langosch K, Janke S, Wagner I, et
al: Role of Fra-2 in breast cancer: influence on tumor cell
invasion and motility. Breast Cancer Res Treat. 107:337–347. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Syeed N, Husain SA, Abdullah S, Sameer AS,
Chowdri NA, Nanda MS and Siddiqi MA: Caveolin-1 promotes mammary
tumorigenesis: mutational profile of the Kashmiri population. Asian
Pac J Cancer Prev. 11:689–696. 2010.PubMed/NCBI
|
|
32
|
Gasser S, Orsulic S, Brown EJ and Raulet
DH: The DNA damage pathway regulates innate immune system ligands
of the NKG2D receptor. Nature. 436:1186–1190. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Del Toro-Arreola S, Arreygue-Garcia N,
Aguilar-Lemarroy A, et al: MHC class I-related chain A and B
ligands are differentially expressed in human cervical cancer cell
lines. Cancer Cell Int. 11:152011.PubMed/NCBI
|
|
34
|
Fox CJ, Hammerman PS, Cinalli RM, Master
SR, Chodosh LA and Thompson CB: The serine/threonine kinase Pim-2
is a transcriptionally regulated apoptotic inhibitor. Genes Dev.
17:1841–1854. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chen WW, Chan DC, Donald C, Lilly MB and
Kraft AS: Pim family kinases enhance tumor growth of prostate
cancer cells. Mol Cancer Res. 3:443–451. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Pratap J, Lian JB, Javed A, Barnes GL, van
Wijnen AJ, Stein JL and Stein GS: Regulatory roles of Runx2 in
metastatic tumor and cancer cell interactions with bone. Cancer
Metastasis Rev. 25:589–600. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yanagida O, Kanai Y, Chairoungdua A, et
al: Human L-type amino acid transporter 1 (LAT1): characterization
of function and expression in tumor cell lines. Biochim Biophys
Acta. 1514:291–302. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Nakanishi K, Matsuo H, Kanai Y, et al:
LAT1 expression in normal lung and in atypical adenomatous
hyperplasia and adenocarcinoma of the lung. Virchows Arch.
448:142–150. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
White AR, Multhaup G, Galatis D, et al:
Contrasting, species-dependent modulation of copper-mediated
neurotoxicity by the Alzheimer’s disease amyloid precursor protein.
J Neurosci. 22:365–376. 2002.PubMed/NCBI
|
|
40
|
Tang X, Milyavsky M, Goldfinger N and
Rotter V: Amyloid-beta precursor-like protein APLP1 is a novel p53
transcriptional target gene that augments neuroblastoma cell death
upon genotoxic stress. Oncogene. 26:7302–7312. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Liu L, Scolnick DM, Trievel RC, Zhang HB,
Marmorstein R, Halazonetis TD and Berger SL: p53 sites acetylated
in vitro by PCAF and p300 are acetylated in vivo in response to DNA
damage. Mol Cell Biol. 19:1202–1209. 1999.PubMed/NCBI
|
|
42
|
Lindsey-Boltz LA, Serçin O, Choi JH and
Sancar A: Reconstitution of human claspin-mediated phosphorylation
of Chk1 by the ATR (ataxia telangiectasia-mutated and rad3-related)
checkpoint kinase. J Biol Chem. 284:33107–33114. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Praetorius-Ibba M, Wang QE, Wani G,
El-Mahdy MA, Zhu Q, Qin S and Wani AA: Role of Claspin in
regulation of nucleotide excision repair factor DDB2. DNA Repair.
6:578–587. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Chini CC and Chen J: Claspin, a regulator
of Chk1 in DNA replication stress pathway. DNA Repair. 3:1033–1037.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Tajeddine N, Gala JL, Louis M, Van Schoor
M, Tombal B and Gailly P: Tumor-associated antigen preferentially
expressed antigen of melanoma (PRAME) induces caspase-independent
cell death in vitro and reduces tumorigenicity in vivo. Cancer Res.
65:7348–7355. 2005. View Article : Google Scholar
|
